Federal Register - February 4, 2021
Versión en texto ¿Qué es?Dateas es un sitio independiente no afiliado a entidades gubernamentales. La fuente de los documentos PDF aquí publicados es la entidad gubernamental indicada en cada uno de ellos. Las versiones en texto son transcripciones no oficiales que realizamos para facilitar el acceso y la búsqueda de información, pero pueden contener errores o no estar completas.
Fuente: Federal Register
8210
Federal Register / Vol. 86, No. 22 / Thursday, February 4, 2021 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health National Institute of General Medical Sciences; Notice of Closed Meeting Pursuant to section 10d of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552bc4 and 552bc6, Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: NIGMS Initial Review Group; Training and Workforce Development SubcommitteeD To Review MARC, URISE
and GRISE Applications.
Date: March 9, 2021.
Time: 10:30 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Natcher Building, 45 Center Drive, Bethesda, MD 20892 Video Meeting.
Contact Person: Tracy Koretsky, Ph.D., Scientific Review Officer, Office of Scientific Review, National Institute of General Medical Sciences, National Institutes of Health, 45
Center Drive, MSC 6200, Room 3AN.12F, Bethesda, MD 20892, 301 594 2886, tracy.koretsky@nih.gov.
Catalogue of Federal Domestic Assistance Program Nos. 93.375, Minority Biomedical Research Support; 93.821, Cell Biology and Biophysics Research; 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.862, Genetics and Developmental Biology Research; 93.88, Minority Access to Research Careers; 93.96, Special Minority Initiatives; 93.859, Biomedical Research and Research Training, National Institutes of Health, HHS
Dated: January 29, 2021.
Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy.
FR Doc. 202102308 Filed 2321; 8:45 am BILLING CODE 414001P
jbell on DSKJLSW7X2PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
amended, notice is hereby given of a meeting of the National Cancer Institute Clinical Trials and Translational Research Advisory Committee.
The meeting will be held as a virtual meeting and is open to the public.
Individuals who plan to view the virtual meeting and need special assistance or other reasonable accommodations to view the meeting, should notify the Contact Person listed below in advance of the meeting. The meeting will be videocast and can be accessed from the NIH Videocasting and Podcasting website http videocast.nih.gov.
Name of Committee: National Cancer Institute Clinical Trials and Translational Research Advisory Committee.
Date: March 17, 2021.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: Strategic Discussion of NCIs Clinical and Translational Research Programs.
Place: National Cancer Institute, 9609
Medical Center Drive, Rockville, MD 20850
Virtual Meeting.
Contact Person: Sheila A. Prindiville, MD, MPH, Director, Coordinating Center for Clinical Trials, National Cancer Institute, National Institutes of Health, 9609 Medical Center Drive, Room 6W136, Rockville, MD
20850, 2402766173, prindivs@
mail.nih.gov.
Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person.
Information is also available on the Institutes/Centers home page: http
deainfo.nci.nih.gov/advisory/ctac/ctac.htm, where an agenda and any additional information for the meeting will be posted when available.
Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS
Pursuant to section 10d of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552bc4 and 552bc6, Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; NIDDK Multi-Center Clinical Trial Cooperative Agreement U01
Clinical Trial Required.
Date: March 2, 2021.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892 Telephone Conference Call.
Contact Person: Ann A. Jerkins, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, 6707 Democracy Boulevard, Room 7119, Bethesda, MD 208925452, 3015942242, jerkinsa@niddk.nih.gov.
Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS
Dated: January 29, 2021.
Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy.
FR Doc. 202102306 Filed 2321; 8:45 am BILLING CODE 414001P
FR Doc. 202102298 Filed 2321; 8:45 am
National Eye Institute; Amended Notice of Meeting
National Institutes of Health
Notice is hereby given of a change in the meeting of the National Advisory Eye Council, February 12, 2021, 10:00
a.m. to 4:00 p.m., National Eye Institute,
Pursuant to section 10a of the Federal Advisory Committee Act, as
Jkt 253001
National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Cancer Institute; Notice of Meeting
17:13 Feb 03, 2021
National Institutes of Health
Dated: January 27, 2021.
Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy.
BILLING CODE 414001P
VerDate Sep<11>2014
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
E:FRFM04FEN1.SGM
04FEN1